These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 15161956

  • 21. Mycophenolate mofetil introduction stabilizes and subsequent cyclosporine A reduction slightly improves kidney function in pediatric renal transplant patients: a retrospective analysis.
    Benz K, Plank C, Griebel M, Montoya C, Dötsch J, Klare B.
    Pediatr Transplant; 2006 May; 10(3):331-6. PubMed ID: 16677357
    [Abstract] [Full Text] [Related]

  • 22. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs.
    Flechner SM, Goldfarb D, Solez K, Modlin CS, Mastroianni B, Savas K, Babineau D, Kurian S, Salomon D, Novick AC, Cook DJ.
    Transplantation; 2007 Apr 15; 83(7):883-92. PubMed ID: 17460558
    [Abstract] [Full Text] [Related]

  • 23. BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen.
    Geddes CC, Gunson R, Mazonakis E, Wan R, Thomson L, Clancy M, Carman WF.
    Transpl Infect Dis; 2011 Apr 15; 13(2):109-16. PubMed ID: 21457419
    [Abstract] [Full Text] [Related]

  • 24. Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression.
    Lou HX, Vathsala A.
    Transplant Proc; 2004 Sep 15; 36(7):2090-1. PubMed ID: 15518756
    [Abstract] [Full Text] [Related]

  • 25. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
    Bunnapradist S, Daswani A, Takemoto SK.
    Transplantation; 2003 Jul 15; 76(1):10-5. PubMed ID: 12865780
    [Abstract] [Full Text] [Related]

  • 26. Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil.
    Jain S, Metcalfe M, White SA, Furness PN, Nicholson ML.
    Transplant Proc; 2001 May 15; 33(3):2165-6. PubMed ID: 11377488
    [No Abstract] [Full Text] [Related]

  • 27. Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation.
    Filler G, Foster J, Berard R, Mai I, Lepage N.
    Transplant Proc; 2004 Jun 15; 36(5):1327-31. PubMed ID: 15251324
    [Abstract] [Full Text] [Related]

  • 28. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
    Peng LK, Xie XB, Peng FH, Wang Y, Jiang Y, Lan GB, Fang CH, Nie MH.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb 15; 32(1):59-62. PubMed ID: 17344588
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of mycophenolate mofetil on kidney graft function and body weight in patients with chronic allograft nephropathy.
    Grebe SO, Mueller TF, Troeltsch M, Ebel H, Lange H.
    Transplant Proc; 2004 Dec 15; 36(10):2974-8. PubMed ID: 15686673
    [Abstract] [Full Text] [Related]

  • 32. Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy.
    Suwelack B, Gerhardt U, Hohage H.
    Am J Transplant; 2004 Apr 15; 4(4):655-62. PubMed ID: 15023160
    [Abstract] [Full Text] [Related]

  • 33. Chronic allograft nephropathy and mycophenolate mofetil introduction in paediatric renal recipients.
    Kerecuk L, Taylor J, Clark G.
    Pediatr Nephrol; 2005 Nov 15; 20(11):1630-5. PubMed ID: 16133052
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
    Remuzzi G, Cravedi P, Costantini M, Lesti M, Ganeva M, Gherardi G, Ene-Iordache B, Gotti E, Donati D, Salvadori M, Sandrini S, Segoloni G, Federico S, Rigotti P, Sparacino V, Ruggenenti P.
    J Am Soc Nephrol; 2007 Jun 15; 18(6):1973-85. PubMed ID: 17460145
    [Abstract] [Full Text] [Related]

  • 37. Conversion to mycophenolate mofetil from azathioprine shows significant positive effect on graft function in long-term past-kidney transplantation stable-state patients.
    Nakazawa S, Kishikawa H, Kawamura M, Ueda N, Hirai T, Nishimura K.
    Transplant Proc; 2014 Jun 15; 46(2):411-4. PubMed ID: 24655976
    [Abstract] [Full Text] [Related]

  • 38. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T, Mendez R, Yang HC, Weinstein S, Jensik S, Steinberg S, Prograf Study Group.
    Transplantation; 2003 Apr 27; 75(8):1213-20. PubMed ID: 12717205
    [Abstract] [Full Text] [Related]

  • 39. Mycophenolate mofetil tolerability and dose changes in tacrolimus-treated renal allograft recipients.
    Pascual J, Ocaña J, Marcén R, Fernández A, Galeano C, Alarcón MC, Burgos FJ, Villafruela JJ, Ortuño J.
    Transplant Proc; 2006 Oct 27; 38(8):2398-9. PubMed ID: 17097946
    [Abstract] [Full Text] [Related]

  • 40. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan 27; 65(2):235-41. PubMed ID: 9458021
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.